A novel cytogenetic abnormality t(7;8)(p11.2:q11.2) and a four-way Philadelphia translocation in an imatinib mesylate-resistant chronic myeloid leukemia patient

Oncology Letters

Volumn 5, Issue 2, 2013, Pages 617-620

  Al Achkar, Walid ^a   Aljapawe, Abdulmunim ^a   Almedani, Suher ^a   Liehr, Thomas ^b   Wafa, Abdulsamad ^a  

^a DEPARTMENT OF MOLECULAR BIOLOGY AND BIOTECHNOLOGY   (Syrian Arab Republic)

^b JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Array proven multicolor banding; Chronic myeloid leukemia; Fluorescence in situ hybridization; Four way philadelphia translocation; Imatinib mesylate

Indexed keywords

ALKALINE PHOSPHATASE; ALLOPURINOL; BCR ABL PROTEIN; HYDROXYUREA; IMATINIB; LACTATE DEHYDROGENASE;

ACUTE BIPHENOTYPIC LEUKEMIA; ADULT; ARTICLE; CASE REPORT; CHROMOSOME 9; CHROMOSOME BANDING PATTERN; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; DNA SEQUENCE; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; FLUORESCENCE MICROSCOPY; GENE MUTATION; HUMAN; IMMUNOPHENOTYPING; KARYOTYPING; METAPHASE CHROMOSOME; PHILADELPHIA 1 CHROMOSOME; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLENOMEGALY; WEIGHT REDUCTION;

EID: 84871584791     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.1037     Document Type: Article

References (23)

1. Sawyers CL: Chronic myeloid leukemia. N Engl J Med 340: 1330-1340, 1999.
2. Johansson B, Fioretos T and Mitelman F: Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Acta Haematol 107: 76-94, 2002.
3. Adriana Z and Al Bahar S: Novel four-way Ph translocation t(9;22;7;1)(q34;q11;q22;p13) in a chronic myeloid leukemia patient receiving tyrosine kinase inhibitor therapy. Int J Hematol 95: 315-319, 2012.
4. Sandberg AA: The Chromosomes in Human Cancer and Leukemia. 2nd edition. Elsevier Science, New York, NY, pp151-172, 1990.
5. Druker BJ, Guilhot F, O'Brien SG, Gathmann I, Kantarjian H, Gattermann N, et al: Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med 355: 2408-2417, 2006.
6. Reid A, Gribble SM, Huntly BJ, Andrews KM, Campbell L, Grace CD, Wood ME, Green AR and Nacheva EP: Variant Philadelphia translocations in chronic myeloid leukaemia can mimic typical blast crisis chromosome abnormalities or classic t(9;22): a report of two cases. Br J Haematol 113: 439-442, 2001.
7. Al-Achkar W, Wafa A, Klein E and Aljapawe A: Biclonal myelodysplastic syndrome involving six chromosomes and monoallelic loss of RB1-A rare case. Mol Cytogenet 4: 16, 2011.
8. Shaffer L, Slovak M and Cambell L (eds): ISCN (2009): An International System for Human Cytogenetic Nomenclature. 1stedition. S. Karger AG, Basel, 2009.
9. Chien JH, Tang JL, Chen RL, Li CC and Lee CP: Detection of BCR-ABL gene mutations in Philadelphia chromosome positive leukemia patients resistant to STI-571 cancer therapy. Leuk Res 32: 1724-1734, 2008.
10. Rothe G and Schmitz G: Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow Cytometry and Image Analysis. Leukemia 10: 877-895, 1996.
11. Mitelman F, Johansson B and Mertens F: Mitelman Database of Chromosome Aberrations in Cancer. http://cgap.nci.nih.gov/Chromosomes/Mitelman. Accessed October 3, 2012.
12. Reid AG, Huntly BJP, Grace C, Green AR and Nacheva EP: Survival implications of molecular heterogeneity in variant Philadelphia-positive chronic myeloid leukaemia. Br J Haematol 121: 419-427, 2003.
13. Bennour A, Sennana H, Laatiri MA, Khelif A and Saad A: A masked BCR/ABL rearrangement in a case of chronic myeloid leukemia with translocation t(3;9)(p14;q34). Cancer Genet Cytogenet 181: 72-74, 2008.
14. Hochhaus A, Kreil S, Corbin AS, La Rosée P, Müller MC, LahayeT, Hanfstein B, Schoch C, Cross NCP, Berger U, Gschaidmeier H, Druker BJ and Hehlmann R: Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy. Leukemia 16: 2190-2196, 2002.
15. Bacher U, Schnitter S, Kern W, Hiddemann W, Haferlach T and Schoch C: The incidence of submicroscopic deletions in reciprocal translocations is similar in acute myeloid leukemia, BCR-ABL positive acute lymphoblastic leukemia and chronic myeloid leukemia. Haematologica 90: 558-559, 2005.
16. Bennour A, Sennana H, Laatiri MA, Elloumi M, Khelif A and Saad A: Molecular cytogenetic characterization of variant Philadelphia translocations in chronic myeloid leukemia: genesis and deletion of derivative chromosome 9. Cancer Genet Cytogenet 194: 30-37, 2009.
17. Brunning RD, Matutes E, Borowitz M, et al: Acute leukaemias of ambiguous lineage. In: World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haemopoietic and Lymphoid Tissues. Jaffe ES, Harris NL, SteinH and VardimanJW (eds). IARC Press, Lyon, France, pp106-107, 2001.
18. Carbonell F, Swansbury J, Min T, Matutes E, Farahat N, BuccheriV, Morilla R, Secker-Walker L and Catovsky D: Cytogenetic findings in acute biphenotypic leukaemia. Leukemia 10: 1283-1287, 1996.
19. Downward J: Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer 3: 11-22, 2003.
20. Wlodarska I, Martin-Garcia N, Achten R, De Wolf-Peeters C, Pauwels P, Tulliez M, de Mascarel A, Briere J, Patey M, Hagelmeijer A and Gaulard P: Fluorescence in situ hybridization study of chromosome 7 aberrations in hepatosplenic T-cell lymphoma: isochromosome 7q as a common abnormality accumulating in forms with features of cytologic progression. Genes Chromosomes Cancer 33: 243-251, 2002.
21. Qin LX: Chromosomal aberrations related to metastasis of human solid tumors. World J Gastroenterol 8: 769-776, 2002.
22. Mancini M, Scappaticci D, Cimino G, Nanni M, Derme V, EliaL, Tafuri A, Vignetti M, Vitale A, Cuneo A, CastoldiG, SaglioG, Pane F, Mecucci C, Camera A, Specchia G, TedeschiA, DiRaimondo F, Fioritoni G, Fabbiano F, MarmontF, FerraraF, Cascavilla N, Todeschini G, Nobile F, Kropp MG, Leoni P, Tabilio A, Luppi M, Annino L, Mandelli F and Foà R: A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol. Blood 105: 3434-3441, 2005.
23. Andreasson P, Johansson B, Arheden K, Billstrom R, Mitelman F and Hoglund M: Deletions of CDKN1B and ETV6 in acute myeloid leukemia and myelodysplastic syndromes without cytogenetic evidence of 12p abnormalities. Genes Chromosomes Cancer 19: 77-83, 1997.